These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15323184)

  • 21. Towards a new "AGE" of the chemistry and pathophysiology of the Maillard reaction.
    Münch G; Colaco C
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):ix-x. PubMed ID: 9846882
    [No Abstract]   [Full Text] [Related]  

  • 22. Dicarbonyl intermediates in the maillard reaction.
    Thornalley PJ
    Ann N Y Acad Sci; 2005 Jun; 1043():111-7. PubMed ID: 16037229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 9th International Symposium on the Maillard Reaction. Preface.
    Schleicher E; Somoza V; Schieberle P
    Ann N Y Acad Sci; 2008 Apr; 1126():xiii. PubMed ID: 18448788
    [No Abstract]   [Full Text] [Related]  

  • 24. A procedure for the rapid screening of Maillard reaction inhibitors.
    Fatima S; Jairajpuri DS; Saleemuddin M
    J Biochem Biophys Methods; 2008 Apr; 70(6):958-65. PubMed ID: 18096239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formation mechanisms of melanoidins and fluorescent pyridinium compounds as advanced glycation end products.
    Hayase F; Usui T; Ono Y; Shirahashi Y; Machida T; Ito T; Nishitani N; Shimohira K; Watanabe H
    Ann N Y Acad Sci; 2008 Apr; 1126():53-8. PubMed ID: 18079473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of the Maillard reaction on the physical properties and cell interactions of collagen.
    Avery NC; Bailey AJ
    Pathol Biol (Paris); 2006 Sep; 54(7):387-95. PubMed ID: 16962252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The other side of the Maillard reaction.
    Nagaraj RH; Biswas A; Miller A; Oya-Ito T; Bhat M
    Ann N Y Acad Sci; 2008 Apr; 1126():107-12. PubMed ID: 18448802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Labeling studies on the formation pathway of Nepsilon-carboxymethyllysine in maillard-type reactions.
    Kasper M; Schieberle P
    Ann N Y Acad Sci; 2005 Jun; 1043():59-62. PubMed ID: 16037222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Native protein glycoxidation and aging.
    Meli M; Frey J; Perier C
    J Nutr Health Aging; 2003; 7(4):263-6. PubMed ID: 12917752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay between the maillard reaction and lipid peroxidation in biochemical systems.
    Hidalgo FJ; Zamora R
    Ann N Y Acad Sci; 2005 Jun; 1043():319-26. PubMed ID: 16037254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.
    Miyata T; Yamamoto M; Izuhara Y
    Ann N Y Acad Sci; 2005 Jun; 1043():740-9. PubMed ID: 16037301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein glycation, diabetes, and aging.
    Ulrich P; Cerami A
    Recent Prog Horm Res; 2001; 56():1-21. PubMed ID: 11237208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Amadori product on protein: structure and reactions.
    Baynes JW; Watkins NG; Fisher CI; Hull CJ; Patrick JS; Ahmed MU; Dunn JA; Thorpe SR
    Prog Clin Biol Res; 1989; 304():43-67. PubMed ID: 2675036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effects of tenilsetam on the Maillard reaction.
    Shoda H; Miyata S; Liu BF; Yamada H; Ohara T; Suzuki K; Oimomi M; Kasuga M
    Endocrinology; 1997 May; 138(5):1886-92. PubMed ID: 9112383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxyl radicals are essential reagents in the oxidation steps of the Maillard reaction leading to generation of advanced glycation end products.
    Spiteller G
    Ann N Y Acad Sci; 2008 Apr; 1126():128-33. PubMed ID: 18448806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced glycation end products/peptides: an in vivo investigation.
    Lapolla A; Fedele D; Reitano R; Bonfante L; Pastori G; Seraglia R; Tubaro M; Traldi P
    Ann N Y Acad Sci; 2005 Jun; 1043():267-75. PubMed ID: 16037247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines.
    Szwergold BS
    Med Hypotheses; 2005; 65(2):337-48. PubMed ID: 15922110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of aminoguanidine on the glycation.
    Oimomi M; Igaki N; Ohara T; Sakai M; Nakamichi T; Hata F; Baba S
    Kobe J Med Sci; 1989 Dec; 35(5-6):255-9. PubMed ID: 2635241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of carbonyl compounds on red blood cells deformability.
    Iwata H; Ukeda H; Maruyama T; Fujino T; Sawamura M
    Biochem Biophys Res Commun; 2004 Aug; 321(3):700-6. PubMed ID: 15358163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced glycation end product (age) inhibitors and their therapeutic implications in diseases.
    Takeuchi M; Yamagishi S; Iwaki M; Nakamura K; Imaizumi T
    Int J Clin Pharmacol Res; 2004; 24(2-3):95-101. PubMed ID: 15689055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.